Immunization, measles second dose in Afghanistan
Afghanistan: Immunization, measles second dose was 44.0% in 2024. ▲ Rising
Immunization, measles second dose in Afghanistan, 2004–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
The most recent figure for immunization, measles second dose in Afghanistan is 44.0%, measured in 2024.
Compared with earlier readings it is up 4.8% on the previous year and unchanged over ten years.
Over the whole period, immunization, measles second dose in Afghanistan peaked at 46.0% in 2018 and was at its lowest, 2.0%, in 2004.
Afghanistan ranks 172nd of 178 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 21 years of available data.
Immunization, measles second dose in Afghanistan, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2004 | 2.0% | — |
| 2005 | 9.0% | +350.0% |
| 2006 | 18.0% | +100.0% |
| 2007 | 4.0% | -77.8% |
| 2008 | 23.0% | +475.0% |
| 2009 | 24.0% | +4.3% |
| 2010 | 29.0% | +20.8% |
| 2011 | 31.0% | +6.9% |
| 2012 | 33.0% | +6.5% |
| 2013 | 38.0% | +15.2% |
| 2014 | 44.0% | +15.8% |
| 2015 | 42.0% | -4.5% |
| 2016 | 40.0% | -4.8% |
| 2017 | 38.0% | -5.0% |
| 2018 | 46.0% | +21.1% |
| 2019 | 37.0% | -19.6% |
| 2020 | 38.0% | +2.7% |
| 2021 | 37.0% | -2.6% |
| 2022 | 42.0% | +13.5% |
| 2023 | 42.0% | +0.0% |
| 2024 | 44.0% | +4.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 13.3% | 2.0% | 24.0% | 6 |
| 2010s | 37.8% | 29.0% | 46.0% | 10 |
| 2020s | 40.6% | 37.0% | 44.0% | 5 |
Countries ranked near Afghanistan
- 170 Argentina 46.0% compare
- 170 Madagascar 46.0% compare
- 172 Mozambique 44.0% compare
- 174 Yemen 40.0% compare
- 175 Sudan 36.0% compare
More health data for Afghanistan
- Un projection of annual infant deaths, annual growth rate -1.45 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 812.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 14,735 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 19 (2025)
- Population ages 00-04, female, annual growth rate 1.78 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0002 units per US$ of GDP (2024)
- Population ages 00-04, female, per capita 0.077 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.75 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0002 units per US$ of GDP (2024)
Frequently asked questions
- What is immunization, measles second dose in Afghanistan?
- Immunization, measles second dose in Afghanistan was 44.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Afghanistan?
- The highest recorded value was 46.0% in 2018.
- What is the lowest immunization, measles second dose recorded in Afghanistan?
- The lowest recorded value was 2.0% in 2004.
- How does Afghanistan rank for immunization, measles second dose?
- Afghanistan ranks 172nd out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Afghanistan?
- Over the last ten years it is unchanged. The long-run trend across the full record is rising.
- Where does this Afghanistan data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 21 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.